Literature DB >> 15040516

Anthrax in America 2001-2003.

Shivang G Joshi1, Holly Berkovits Cymet, Gary Kerkvliet, Tyler Cymet.   

Abstract

Anthrax caused by Bacillus anthracis in humans is rare. Two recent outbreaks that were intentionally caused occurred among postal employees, politicians, and journalists in the United States. This has caused tremendous fear, and our experience with these "anthrax incidents" has changed our views on the natural history of this disease in people. In this paper, we review the lifecycle and biology of this micro-organism. Anthrax that occurs from a weaponized form of this micro-organism has a specific clinical presentation that requires a suspicion of anthrax exposure to be diagnosed. New methods of testing for anthrax have been developed and may simplify diagnosis in the future. The range of illness caused by B. anthracis from the molecular level to the clinical symptoms is discussed. We also review the diagnostic criteria and differential diagnosis as well as treatment of this condition.

Entities:  

Mesh:

Year:  2004        PMID: 15040516      PMCID: PMC2594885     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  24 in total

1.  Recognition and treatment of anthrax.

Authors:  D R Nalin
Journal:  JAMA       Date:  1999-11-03       Impact factor: 56.272

2.  Studies on respiratory infection. I. The influence of particle size on respiratory infection with anthrax spores.

Authors:  H A DRUETT; D W HENDERSON; L PACKMAN; S PEACOCK
Journal:  J Hyg (Lond)       Date:  1953-09

3.  Pathophysiological and biochemical changes in anthrax.

Authors:  J S Walker; R E Lincoln; F Klein
Journal:  Fed Proc       Date:  1967-09

4.  The Sverdlovsk anthrax outbreak of 1979.

Authors:  M Meselson; J Guillemin; M Hugh-Jones; A Langmuir; I Popova; A Shelokov; O Yampolskaya
Journal:  Science       Date:  1994-11-18       Impact factor: 47.728

Review 5.  Development of novel vaccines against anthrax in man.

Authors:  A V Stepanov; L I Marinin; A P Pomerantsev; N A Staritsin
Journal:  J Biotechnol       Date:  1996-01-26       Impact factor: 3.307

6.  Germination of Bacillus anthracis spores within alveolar macrophages.

Authors:  C Guidi-Rontani; M Weber-Levy; E Labruyère; M Mock
Journal:  Mol Microbiol       Date:  1999-01       Impact factor: 3.501

7.  The statistical analysis of truncated data: application to the Sverdlovsk anthrax outbreak.

Authors:  R Brookmeyer; N Blades; M Hugh-Jones; D A Henderson
Journal:  Biostatistics       Date:  2001-06       Impact factor: 5.899

8.  Outbreak of oral-oropharyngeal anthrax: an unusual manifestation of human infection with Bacillus anthracis.

Authors:  T Sirisanthana; N Navachareon; P Tharavichitkul; V Sirisanthana; A E Brown
Journal:  Am J Trop Med Hyg       Date:  1984-01       Impact factor: 2.345

9.  The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis.

Authors:  D L Stevens; A E Gibbons; R Bergstrom; V Winn
Journal:  J Infect Dis       Date:  1988-07       Impact factor: 5.226

10.  Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States.

Authors:  J A Jernigan; D S Stephens; D A Ashford; C Omenaca; M S Topiel; M Galbraith; M Tapper; T L Fisk; S Zaki; T Popovic; R F Meyer; C P Quinn; S A Harper; S K Fridkin; J J Sejvar; C W Shepard; M McConnell; J Guarner; W J Shieh; J M Malecki; J L Gerberding; J M Hughes; B A Perkins
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

View more
  2 in total

1.  The phenotypic and genotypic characterization of Bacillus anthracis isolates from Iran.

Authors:  Gholamreza Moazeni Jula; Morteza Sattari; Reza Banihashemi; Hossein Razzaz; Alireza Sanchouli; Keyvan Tadayon
Journal:  Trop Anim Health Prod       Date:  2010-11-30       Impact factor: 1.559

Review 2.  Anti-infective immunoadhesins from plants.

Authors:  Keith Wycoff; James Maclean; Archana Belle; Lloyd Yu; Y Tran; Chad Roy; Frederick Hayden
Journal:  Plant Biotechnol J       Date:  2015-08-04       Impact factor: 9.803

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.